drugset / Trial / NCT07346846
A Study of BGM-2121 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study is to explore the safety, tolerability, pharmacokinetics, and preliminary efficacy of BGM-2121 in adult patients with advanced solid tumors.
Timeline
- Start
- 2026-03-10
- Primary completion
- 2027-11
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGM-2121 | Unknown | — | — |